Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
03:58pm, Monday, 12'th Jan 2026
Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday in Sa
Gilead Sciences, Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:46pm, Monday, 12'th Jan 2026
Gilead Sciences, Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history
09:21am, Monday, 12'th Jan 2026
Daniel O'Day, Gilead Sciences CEO and chairman, joins 'Squawk Box' to discuss the advances in medicine, what to expect at the JPMorgan Healthcare Conference today, the company's Yeztugo HIV medication
Healthcare Dividend Stocks: The Recession-Proof Income Play for 2026
09:41am, Saturday, 10'th Jan 2026
If a recession were to hit, it's a foregone conclusion that people won't stop taking their prescriptions, and they won't cancel major medical treatments.
Here's Why Gilead Sciences (GILD) is a Strong Momentum Stock
10:50am, Wednesday, 07'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Gilead Sciences, Inc. $GILD Shares Bought by Childress Capital Advisors LLC
05:08am, Wednesday, 07'th Jan 2026
Childress Capital Advisors LLC raised its holdings in Gilead Sciences, Inc. (NASDAQ: GILD) by 68.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the S
OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead's Drug Candidate
07:00am, Tuesday, 06'th Jan 2026
DALLAS--(BUSINESS WIRE)--OncoNano Medicine, Inc. (“OncoNano”) today announced a research collaboration with Gilead Sciences, Inc. (Nasdaq: GILD) (“Gilead”) to evaluate OncoNano's ON-BOARD™ e
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors
07:00pm, Monday, 05'th Jan 2026
Gilead Sciences (GILD) concluded the recent trading session at $118.3, signifying a -2.71% move from its prior day's close.
Railway Pension Investments Ltd Purchases 42,200 Shares of Gilead Sciences, Inc. $GILD
07:21am, Monday, 05'th Jan 2026
Railway Pension Investments Ltd increased its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 3.1% in the undefined quarter, according to its most recent disclosure with the Securities and Exchang
CWA Asset Management Group LLC Has $6.08 Million Position in Gilead Sciences, Inc. $GILD
04:25am, Monday, 05'th Jan 2026
CWA Asset Management Group LLC reduced its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 16.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securiti
Brookwood Investment Group LLC Invests $681,000 in Gilead Sciences, Inc. $GILD
04:06am, Sunday, 04'th Jan 2026
Brookwood Investment Group LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ: GILD) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. T
3 Cash-Flow Machines Investors May Want Heading Into 2026
01:46pm, Friday, 02'nd Jan 2026
Of the host of financial metrics investors might consider when deciding whether to buy shares of a target company, cash flow is among the most important. Operating cash flow is a reflection of how a f
Bank Pictet & Cie Europe AG Boosts Holdings in Gilead Sciences, Inc. $GILD
03:34am, Friday, 02'nd Jan 2026
Bank Pictet and Cie Europe AG lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 502.8% during the undefined quarter, according to its most recent disclosure with the Securities and
Why Gilead Sciences (GILD) Dipped More Than Broader Market Today
06:50pm, Tuesday, 30'th Dec 2025
In the latest trading session, Gilead Sciences (GILD) closed at $123.18, marking a -1.38% move from the previous day.
Diversified Trust Co Increases Holdings in Gilead Sciences, Inc. $GILD
05:42am, Tuesday, 30'th Dec 2025
Diversified Trust Co raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 24.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commi
